Cargando…
ARumenamides: A novel class of potential antiarrhythmic compounds
Background: Most therapeutics targeting cardiac voltage-gated sodium channels (Nav1.5) attenuate the sodium current (I(Na)) conducted through the pore of the protein. Whereas these drugs may be beneficial for disease states associated with gain-of-function (GoF) in Nav1.5, few attempts have been mad...
Autores principales: | Abdelsayed, Mena, Page, Dana, Ruben, Peter C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554508/ https://www.ncbi.nlm.nih.gov/pubmed/36249789 http://dx.doi.org/10.3389/fphar.2022.976903 |
Ejemplares similares
-
Mechanisms underlying the antiarrhythmic effect of ARumenamide-787 in experimental models of the J wave syndromes and hypothermia
por: Di Diego, José M., et al.
Publicado: (2023) -
A thermosensitive mutation alters the effects of lacosamide on slow inactivation in neuronal voltage-gated sodium channels, Na(V)1.2
por: Abdelsayed, Mena, et al.
Publicado: (2013) -
Late Sodium Current Inhibitors as Potential Antiarrhythmic Agents
por: Horváth, Balázs, et al.
Publicado: (2020) -
Effects of Amiodarone and N-desethylamiodarone on Cardiac Voltage-Gated Sodium Channels
por: Ghovanloo, Mohammad-Reza, et al.
Publicado: (2016) -
Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
por: El-Battrawy, Ibrahim, et al.
Publicado: (2019)